Name:
Tifcemalimab Biosimilar, Anti-CD272/BTLA
Host species:
Chimeric
Species reactivity:
Human
Form:
solution
Storage buffer:
0.01M PBS, pH 7.4.
Concentration:
1 mg/ml
Purity:
>95% by SDS-PAGE.category:Monoclonal
Isotype:
IgG4-kappa
Applications:
Biosimilar
For research use only. We do not sell to patients.
Target:
B- and T-lymphocyte attenuator, BTLA, CD272, B- and T-lymphocyte-associated protein
Purification:
Protein A or G purified from cell culture supernatant.
Endotoxin level:
Please contact with the lab for this information.
Expression system:
MammalianQ7Z6A9https://www.ncbi.nlm.nih.gov/protein/Q7Z6A9
Stability and Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4C short term
1-2 weeks:
.Store at -20 C 12 months. Store at -80C long term.
Alternative Names:
JS004, Icatolimab, CAS: 2236068-83-8Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Pan Cytokeratin Antibody
Alexa Fluor® 647-conjugated AffiniPure Goat Anti-Rabbit IgG H&L